Selected research
Industry Research
Complementary DNA Microarrays (cDNA) Industry Research Report 2026
Market perspective
The global Complementary DNA Microarrays (cDNA) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Complementary DNA Microarrays (cDNA) is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Complementary DNA Microarrays (cDNA) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Complementary DNA Microarrays (cDNA) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Complementary DNA Microarrays (cDNA) include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Complementary DNA Microarrays (cDNA) market in revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Complementary DNA Microarrays (cDNA).
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Complementary DNA Microarrays (cDNA) Market by Company
Illumnia
Affymetrix
Agilent
Scienion AG
Applied Microarrays
Arrayit
Sengenics
Biometrix Technology
Savyon Diagnostics
WaferGen
Complementary DNA Microarrays (cDNA) Segment by Type
Gene expression
Genotyping
Genome cytogenetics
Complementary DNA Microarrays (cDNA) Segment by Application
Oncology
Non-invasive pregnancy testing(NIPT)
Hypertension
diabetes
Nervous system diseases
Other
Complementary DNA Microarrays (cDNA) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Complementary DNA Microarrays (cDNA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Complementary DNA Microarrays (cDNA) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Complementary DNA Microarrays (cDNA).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Complementary DNA Microarrays (cDNA) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Complementary DNA Microarrays (cDNA) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Complementary DNA Microarrays (cDNA) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gene expression
- Genotyping
- Genome cytogenetics
Applications
- Oncology
- Non-invasive pregnancy testing(NIPT)
- Hypertension
- diabetes
- Nervous system diseases
- Other
Companies covered
- Illumnia
- Affymetrix
- Agilent
- Scienion AG
- Applied Microarrays
- Arrayit
- Sengenics
- Biometrix Technology
- Savyon Diagnostics
- WaferGen
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Complementary DNA Microarrays (cDNA) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Gene expression
- 2.2.3 Genotyping
- 2.2.4 Genome cytogenetics
- 2.3 Complementary DNA Microarrays (cDNA) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oncology
- 2.3.3 Non-invasive pregnancy testing(NIPT)
- 2.3.4 Hypertension
- 2.3.5 diabetes
- 2.3.6 Nervous system diseases
- 2.3.7 Other
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Complementary DNA Microarrays (cDNA) Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Complementary DNA Microarrays (cDNA) Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Complementary DNA Microarrays (cDNA) Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Complementary DNA Microarrays (cDNA) Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Complementary DNA Microarrays (cDNA) Production by Manufacturers (2021-2026)
- 3.2 Global Complementary DNA Microarrays (cDNA) Production Value by Manufacturers (2021-2026)
- 3.3 Global Complementary DNA Microarrays (cDNA) Average Price by Manufacturers (2021-2026)
- 3.4 Global Complementary DNA Microarrays (cDNA) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Complementary DNA Microarrays (cDNA) Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Complementary DNA Microarrays (cDNA) Manufacturers, Product Type & Application
- 3.7 Global Complementary DNA Microarrays (cDNA) Manufacturers Established Date
- 3.8 Global Complementary DNA Microarrays (cDNA) Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Illumnia
- 4.1.1 Illumnia Complementary DNA Microarrays (cDNA) Company Information
- 4.1.2 Illumnia Complementary DNA Microarrays (cDNA) Business Overview
- 4.1.3 Illumnia Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 4.1.4 Illumnia Product Portfolio
- 4.1.5 Illumnia Recent Developments
- 4.2 Affymetrix
- 4.2.1 Affymetrix Complementary DNA Microarrays (cDNA) Company Information
- 4.2.2 Affymetrix Complementary DNA Microarrays (cDNA) Business Overview
- 4.2.3 Affymetrix Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 4.2.4 Affymetrix Product Portfolio
- 4.2.5 Affymetrix Recent Developments
- 4.3 Agilent
- 4.3.1 Agilent Complementary DNA Microarrays (cDNA) Company Information
- 4.3.2 Agilent Complementary DNA Microarrays (cDNA) Business Overview
- 4.3.3 Agilent Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 4.3.4 Agilent Product Portfolio
- 4.3.5 Agilent Recent Developments
- 4.4 Scienion AG
- 4.4.1 Scienion AG Complementary DNA Microarrays (cDNA) Company Information
- 4.4.2 Scienion AG Complementary DNA Microarrays (cDNA) Business Overview
- 4.4.3 Scienion AG Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 4.4.4 Scienion AG Product Portfolio
- 4.4.5 Scienion AG Recent Developments
- 4.5 Applied Microarrays
- 4.5.1 Applied Microarrays Complementary DNA Microarrays (cDNA) Company Information
- 4.5.2 Applied Microarrays Complementary DNA Microarrays (cDNA) Business Overview
- 4.5.3 Applied Microarrays Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 4.5.4 Applied Microarrays Product Portfolio
- 4.5.5 Applied Microarrays Recent Developments
- 4.6 Arrayit
- 4.6.1 Arrayit Complementary DNA Microarrays (cDNA) Company Information
- 4.6.2 Arrayit Complementary DNA Microarrays (cDNA) Business Overview
- 4.6.3 Arrayit Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 4.6.4 Arrayit Product Portfolio
- 4.6.5 Arrayit Recent Developments
- 4.7 Sengenics
- 4.7.1 Sengenics Complementary DNA Microarrays (cDNA) Company Information
- 4.7.2 Sengenics Complementary DNA Microarrays (cDNA) Business Overview
- 4.7.3 Sengenics Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 4.7.4 Sengenics Product Portfolio
- 4.7.5 Sengenics Recent Developments
- 4.8 Biometrix Technology
- 4.8.1 Biometrix Technology Complementary DNA Microarrays (cDNA) Company Information
- 4.8.2 Biometrix Technology Complementary DNA Microarrays (cDNA) Business Overview
- 4.8.3 Biometrix Technology Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 4.8.4 Biometrix Technology Product Portfolio
- 4.8.5 Biometrix Technology Recent Developments
- 4.9 Savyon Diagnostics
- 4.9.1 Savyon Diagnostics Complementary DNA Microarrays (cDNA) Company Information
- 4.9.2 Savyon Diagnostics Complementary DNA Microarrays (cDNA) Business Overview
- 4.9.3 Savyon Diagnostics Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 4.9.4 Savyon Diagnostics Product Portfolio
- 4.9.5 Savyon Diagnostics Recent Developments
- 4.10 WaferGen
- 4.10.1 WaferGen Complementary DNA Microarrays (cDNA) Company Information
- 4.10.2 WaferGen Complementary DNA Microarrays (cDNA) Business Overview
- 4.10.3 WaferGen Complementary DNA Microarrays (cDNA) Production, Value and Gross Margin (2021-2026)
- 4.10.4 WaferGen Product Portfolio
- 4.10.5 WaferGen Recent Developments
5 Global Complementary DNA Microarrays (cDNA) Production by Region
- 5.1 Global Complementary DNA Microarrays (cDNA) Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Complementary DNA Microarrays (cDNA) Production by Region: 2021-2032
- 5.2.1 Global Complementary DNA Microarrays (cDNA) Production by Region: 2021-2026
- 5.2.2 Global Complementary DNA Microarrays (cDNA) Production Forecast by Region (2027-2032)
- 5.3 Global Complementary DNA Microarrays (cDNA) Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Complementary DNA Microarrays (cDNA) Production Value by Region: 2021-2032
- 5.4.1 Global Complementary DNA Microarrays (cDNA) Production Value by Region: 2021-2026
- 5.4.2 Global Complementary DNA Microarrays (cDNA) Production Value Forecast by Region (2027-2032)
- 5.5 Global Complementary DNA Microarrays (cDNA) Market Price Analysis by Region (2021-2026)
- 5.6 Global Complementary DNA Microarrays (cDNA) Production and Value, YOY Growth
- 5.6.1 North America Complementary DNA Microarrays (cDNA) Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Complementary DNA Microarrays (cDNA) Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Complementary DNA Microarrays (cDNA) Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Complementary DNA Microarrays (cDNA) Production Value Estimates and Forecasts (2021-2032)
- 5.6.5 South Korea Complementary DNA Microarrays (cDNA) Production Value Estimates and Forecasts (2021-2032)
6 Global Complementary DNA Microarrays (cDNA) Consumption by Region
- 6.1 Global Complementary DNA Microarrays (cDNA) Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Complementary DNA Microarrays (cDNA) Consumption by Region (2021-2032)
- 6.2.1 Global Complementary DNA Microarrays (cDNA) Consumption by Region: 2021-2026
- 6.2.2 Global Complementary DNA Microarrays (cDNA) Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Complementary DNA Microarrays (cDNA) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Complementary DNA Microarrays (cDNA) Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Complementary DNA Microarrays (cDNA) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Complementary DNA Microarrays (cDNA) Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Complementary DNA Microarrays (cDNA) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Complementary DNA Microarrays (cDNA) Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Complementary DNA Microarrays (cDNA) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Complementary DNA Microarrays (cDNA) Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Complementary DNA Microarrays (cDNA) Production by Type (2021-2032)
- 7.1.1 Global Complementary DNA Microarrays (cDNA) Production by Type (2021-2032) & (k units)
- 7.1.2 Global Complementary DNA Microarrays (cDNA) Production Market Share by Type (2021-2032)
- 7.2 Global Complementary DNA Microarrays (cDNA) Production Value by Type (2021-2032)
- 7.2.1 Global Complementary DNA Microarrays (cDNA) Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Complementary DNA Microarrays (cDNA) Production Value Market Share by Type (2021-2032)
- 7.3 Global Complementary DNA Microarrays (cDNA) Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Complementary DNA Microarrays (cDNA) Production by Application (2021-2032)
- 8.1.1 Global Complementary DNA Microarrays (cDNA) Production by Application (2021-2032) & (k units)
- 8.1.2 Global Complementary DNA Microarrays (cDNA) Production Market Share by Application (2021-2032)
- 8.2 Global Complementary DNA Microarrays (cDNA) Production Value by Application (2021-2032)
- 8.2.1 Global Complementary DNA Microarrays (cDNA) Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Complementary DNA Microarrays (cDNA) Production Value Market Share by Application (2021-2032)
- 8.3 Global Complementary DNA Microarrays (cDNA) Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Complementary DNA Microarrays (cDNA) Value Chain Analysis
- 9.1.1 Complementary DNA Microarrays (cDNA) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Complementary DNA Microarrays (cDNA) Production Mode & Process
- 9.2 Complementary DNA Microarrays (cDNA) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Complementary DNA Microarrays (cDNA) Distributors
- 9.2.3 Complementary DNA Microarrays (cDNA) Customers
10 Global Complementary DNA Microarrays (cDNA) Analyzing Market Dynamics
- 10.1 Complementary DNA Microarrays (cDNA) Industry Trends
- 10.2 Complementary DNA Microarrays (cDNA) Industry Drivers
- 10.3 Complementary DNA Microarrays (cDNA) Industry Opportunities and Challenges
- 10.4 Complementary DNA Microarrays (cDNA) Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst